Agnew exits Euro RSCG for Avenue

Avenue HKM CEO Sandy Thomson has recruited a former Novartis colleague to a business director role at the agency.

Sandy Agnew joined last week from Euro RSCG Life MedEd & PR, where she was a senior account director for less than a year.

Prior to Euro RSCG she worked for Novartis, latterly as UK senior health comms manager. Thomson was UK head of health comms at Novartis, where Agnew reported to her, before leaving last year (PRWeek, 15 April 2005).

Agnew, who also worked in regulatory affairs and clinical research for Novartis, shares responsibility for med ed business with fellow business director Cathy McDonnell.

Avenue's main med ed accounts are Plavix (for Sanofi-Aventis/Bristol-Myers Squibb), Keppra (for UCB) and Alvesco (for Altana Pharma).

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.